Sisi Zheng

Title: Sisi Zheng: Innovator in Cancer Treatment

Introduction

Sisi Zheng is a prominent inventor based in Philadelphia, PA, specializing in the development of innovative treatments for cancer. Her work focuses on antibodies that target specific proteins associated with B-cell acute lymphoblastic leukemia. With a commitment to advancing medical science, Zheng has made significant contributions to the field of oncology.

Latest Patents

Zheng holds a patent for "Antibodies for the diagnosis and treatment of B-cell acute lymphoblastic leukemia." This patent describes antibodies that bind to the CD22-Del.ex5-6 protein, providing methods for treating cancers that express or overexpress this protein. The patent outlines a method of treating cancer by contacting cancer cells with an antibody or antibody derivative that selectively binds to the CD22-Del.ex5-6 protein or a specific peptide sequence.

Career Highlights

Zheng is affiliated with The Children's Hospital of Philadelphia, where she conducts her research and develops her innovative treatments. Her work has garnered attention for its potential to improve outcomes for patients suffering from aggressive forms of leukemia.

Collaborations

Zheng collaborates with Andrei Thomas-Tikhonenko, a fellow researcher, to further explore the applications of her patented antibodies in cancer treatment.

Conclusion

Sisi Zheng's contributions to cancer research and treatment exemplify the impact of innovation in medicine. Her patented work on antibodies represents a significant advancement in the fight against B-cell acute lymphoblastic leukemia.